Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma.

Xiao-Yan SiShafei WuHanping WangXiaotong ZhangMengzhao WangXuan ZengLi Zhang

Published in: Thoracic cancer (2018)

Nimotuzumab combined with chemotherapy might be a possible option as first-line therapy in patients with advanced LSCC. EGFR gene copy number examined by FISH might be a possible predictive biomarker.

Keyphrases

copy number
mitochondrial dna
squamous cell carcinoma
locally advanced
genome wide
small cell lung cancer
dna methylation
epidermal growth factor receptor
tyrosine kinase
rectal cancer
radiation therapy
gene expression
bone marrow
mesenchymal stem cells